MALIGNANT NEOPLASM OF KIDNEY, EXCEPT RENAL PELVIS

Clinical trials for MALIGNANT NEOPLASM OF KIDNEY, EXCEPT RENAL PELVIS explained in plain language.

Never miss a new study

Get alerted when new MALIGNANT NEOPLASM OF KIDNEY, EXCEPT RENAL PELVIS trials appear

Sign up with your email to follow new studies for MALIGNANT NEOPLASM OF KIDNEY, EXCEPT RENAL PELVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for advanced kidney cancer patients in Second-Line treatment trial

Disease control Recruiting now

This study is testing whether adding a new drug called SLC-3010 to an existing cancer drug (axitinib) works better than using axitinib alone. It is for adults with advanced kidney cancer that has worsened after their first treatment. The main goal is to see if the combination hel…

Matched conditions: MALIGNANT NEOPLASM OF KIDNEY, EXCEPT RENAL PELVIS

Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

MALIGNANT NEOPLASM OF KIDNEY, EXCEPT RENAL PELVIS

Get alerted when new MALIGNANT NEOPLASM OF KIDNEY, EXCEPT RENAL PELVIS trials appear

New hope for advanced kidney cancer patients in Second-Line treatment trial